Oral cavity cancer management guidelines for low-resource regions.

Developing Countries Humans Mouth Neoplasms / pathology Practice Guidelines as Topic
developing country guidelines low-resource oral cancer oral cavity

Journal

Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541

Informations de publication

Date de publication:
03 2019
Historique:
received: 01 12 2017
revised: 24 07 2018
accepted: 12 09 2018
pubmed: 23 1 2019
medline: 8 10 2020
entrez: 23 1 2019
Statut: ppublish

Résumé

The diagnosis and management of oral cavity cancer has been well described in developed countries, however, in regions with fewer medical resources, alternative methods may need to be used. We outline an approach to evaluation and treatment of oral cavity cancer in low-resource areas. Reviews of the Cochrane and Pubmed databases were performed and literature compiled. Expert opinions from the American and African Head and Neck Societies were also provided. Treatment guidelines for managing oral cavity cancer in low-resource regions are outlined and the level of supporting evidence is defined. Successful treatment typically involves the use of upfront surgical resection of the primary lesion and any involved or at-risk cervical lymph node basins, with adjuvant therapy based on the final pathology findings. In situations where services such as adjuvant therapy and/or appropriate reconstruction are not available, alternative approaches to treatment may be needed.

Sections du résumé

BACKGROUND
The diagnosis and management of oral cavity cancer has been well described in developed countries, however, in regions with fewer medical resources, alternative methods may need to be used. We outline an approach to evaluation and treatment of oral cavity cancer in low-resource areas.
METHODS
Reviews of the Cochrane and Pubmed databases were performed and literature compiled. Expert opinions from the American and African Head and Neck Societies were also provided.
RESULTS
Treatment guidelines for managing oral cavity cancer in low-resource regions are outlined and the level of supporting evidence is defined.
DISCUSSION
Successful treatment typically involves the use of upfront surgical resection of the primary lesion and any involved or at-risk cervical lymph node basins, with adjuvant therapy based on the final pathology findings. In situations where services such as adjuvant therapy and/or appropriate reconstruction are not available, alternative approaches to treatment may be needed.

Identifiants

DOI: 10.1002/hed.25423 PMID: 30666743
pubmed: 30666743
doi: 10.1002/hed.25423
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

799-812

Subventions

Organisme : American Head and Neck Society
Pays : International

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Brian Cervenka (B)

Department of Otolaryngology-Head and Neck Surgery, University of California at Davis, Resident, Sacramento, California.
ORCID: 0000-0003-0747-3161

Patrik Pipkorn (P)

Department of Otolaryngology-Head and Neck Surgery, Washington University, Assistant Professor, St. Louis, Missouri.

Johannes Fagan (J)

Department of Otolaryngology-Head and Neck Surgery, The University of Cape Town, Professor, Cape Town, South Africa.

Mark Zafereo (M)

Department of Head and Neck Surgery, The University of Texas, MD Anderson Cancer Center, Associate Professor, Houston, Texas.

Joyce Aswani (J)

Department of Otolaryngology-Head and Neck Surgery, University of Nairobi, Nairobi, Kenya.

Chege Macharia (C)

Department of General Surgery, AIC Kijabe Hospital, Kijabe, Kenya.

Innocent Kundiona (I)

Department of Surgery, The University of Zimbabwe, Harare, Zimbabwe.

Victor Mashamba (V)

Department of Otorhinolaryngology, Muhimbili National Hospital, Dar es Salaam, Tanzania.

Chad Zender (C)

Department of Otolaryngology-Head and Neck Surgery, Case Western Reserve MC, Cleveland, Ohio.

Michael Moore (M)

Department of Otolaryngology-Head and Neck Surgery, University of California at Davis, Associate Professor, Sacramento, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Sciences sociales › Internationalité › Coopération internationale › Pays en voie de développement › Oral cavity cancer management guidelines for...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Oral cavity cancer management guidelines for...
questionsmedicales.fr › Maladies du système stomatognathique › Maladies de la bouche › Tumeurs de la bouche › Oral cavity cancer management guidelines for...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Assurance de la qualité des soins de santé › Recommandations comme sujet › Guides de bonnes pratiques cliniques comme sujet › Oral cavity cancer management guidelines for...